CHAMPION HF Risk Algorithm (Prototype)
- CHAMPION HF Risk Algorithm (Prototype) — explanation and clinical context
This page provides a prototype, point-based risk stratification tool informed by variables central to pulmonary artery pressure-guided heart failure management (age, NYHA class, prior HF hospitalization, mean pulmonary artery pressure, LVEF, renal function, and NT-proBNP). The CHAMPION randomized trial evaluated the CardioMEMS pulmonary artery pressure monitoring system and demonstrated reductions in HF hospitalizations when clinicians had access to daily pulmonary artery pressure data. Contemporary multisensor/device algorithms (e.g., multisensor/HeartLogic approaches) and registry/post-approval analyses support the utility of hemodynamic and device-derived signals to detect impending decompensation earlier than symptoms alone. This prototype does not reproduce any published CHAMPION 'risk equation' (no public, peer-reviewed set of regression coefficients labelled "CHAMPION HF Risk Algorithm" was identified). Instead, the tool presents a transparent heuristic mapping of common risk markers to a tiered short-term risk estimate for educational/demo use only.
Reference:
Adamson PB, Abraham WT, et al. CHAMPION trial publications and follow-up: Adamson PB et al., (trial rationale/design) and Abraham WT et al., Lancet 2016 (complete follow-up) describing the CardioMEMS/CHAMPION trial methodology and outcomes.
Boehmer JP, et al. A Multisensor Algorithm Predicts Heart Failure Events (MultiSENSE / HeartLogic) — device multisensor prediction work illustrating how device data can predict HF events.
Recent reviews and post-approval studies summarizing CardioMEMS real-world performance and implementation considerations.
Discussion
No discussions yet. Be the first to comment.
Create Note
Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.